news2Introducing GW PharmaceuticalsDiscover more about GW...Meeting patients' needsPatient information can be found here....World leading scienceMore about our scientific collaborations...A valuable ...
http://www.gwpharmaceuticals.org/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
GW Pharma
Lee Berry
Porton D●●●●●●●●nce Park
Sal●●●ury , Wiltshire, SP4 0JQ
GB
View this contact
GW Pharma
Lee Berry
Porton D●●●●●●●●nce Park
Sal●●●ury , Wiltshire, SP4 0JQ
GB
View this contact
Netnames Ltd
Role Netnames Hostmaster
3rd Floo●●●●●●●●ro House
Lo●●on , SE1 1GA
GB
View this contact
BUY YOUR DOMAIN
Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA (R76-LROR)
WHOIS : whois.publicinterestregistry.net
REFERRED :
PAGES IN
THIS WEBSITE
13
SSL
EXTERNAL LINKS
0
SITE IP
185.19.14.34
LOAD TIME
0 sec
SCORE
6.2
GWPharma - Welcome | gwpharmaceuticals.org Reviews
https://gwpharmaceuticals.org
news2Introducing GW PharmaceuticalsDiscover more about GW...Meeting patients' needsPatient information can be found here....World leading scienceMore about our scientific collaborations...A valuable ...
gwpharmaceuticals.org
GWPharma - Sitemap
http://www.gwpharmaceuticals.org/Sitemap.aspx
When was GW established? What is GW Pharmaceuticals? How many staff does GW have? Where is GW located? What are the aims of GW Pharmaceuticals? Does GW carry out research under special licences? Which countries does GW carry out its research in? How do cannabinoids work? Is GW researching other cannabinoids besides THC? What trials has GW conducted? What research is required to obtain regulatory approvals for GW’s products? How are these cannabinoid medications administered to patients? Which stock excha...
GWPharma - R&D
http://www.gwpharmaceuticals.org/r-and-d.aspx
GW Metabolic Research Laboratory. GW’s research explores the potential therapeutic applications of cannabinoids and the endocannabinoid system across a wide range of disease areas. There are over 60 cannabinoid compounds identified to date. GW is researching a large number of cannabinoids, each of which has different effects and applications. Information on cannabinoid compounds and the cannabinoid receptor system. A summary of GW's product pipeline, including Sativex and other research targets.
GWPharma - R&D Collaborations
http://www.gwpharmaceuticals.org/r-and-d-collaborations.aspx
GW Metabolic Research Laboratory. GW is recognised as a world leader in cannabinoid science and works closely with scientific collaborators at academic institutions across the world. These relationships yield new research pathways and valuable intellectual property. GW’s research is increasingly featured in high status peer-reviewed scientific journals. In addition to Professor Pertwee, GW collaborates with a number of other prominent researchers at Aberdeen including Professor Ruth Ross and Professor Ge...
GWPharma - Accessibility
http://www.gwpharmaceuticals.org/Accessibility.aspx
GW Pharmaceuticals recognise the importance of providing a website that is inclusive and available for all user groups. This page explains:. Our approach to making this website accessible;. The facilities that we have provided for different disability groups;. Guidance on how to use particular features;. What to do if you have any questions or feedback for us. Partially Sighted Users - Text size. Colour Blind Users - Colour. To select from dropdown boxes, use up and down arrow keys;. Complex images inclu...
GWPharma - Media
http://www.gwpharmaceuticals.org/media.aspx
Welcome to the media section of the GW website, dedicated to providing useful information for press enquiries. This section contains current and previous press releases, notes to editors, image library and media contact information. For a dedicated page relating to Sativex click here. GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress. London, UK, 9 August 2016: GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, GW, the Company or the Gr.
TOTAL PAGES IN THIS WEBSITE
13
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
The domain www.gwpharmaceuticals.biz is registered by NetNames
The domain name www.gwpharmaceuticals.biz. Has been registered by NetNames. Every domain name comes with free web and email forwarding. To forward your domain name to another web page or site, log into your control panel at www.netnames.com. And change the web forwarding settings.
GWPharma - Welcome
GW’s lead product, Sativex. Is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development. Discover more about GW. Sativex is approved to treat spasticity (muscle stiffness and spasm) due to Multiple Sclerosis, offering relief to patients for a condition that previously had limited treatment options. Patient information can be found here. More about our scientific collaborations. Our areas of therapeutic interest. GW Pharmaceutic...
IIS7
Offering Business Leaders A Unique Opportunity. The Heritage Company offers a unique and fulfilling job opportunity. As a division of Good Will Publishers, Incorporated, Heritage Company reaches out to the families grieving the loss of a loved one. With our unique sponsorship marketing. Method, we enable civic minded business leaders to share their condolences with members of their community by providing the family a beautiful and permanent keepsake volume entitled.
Untitled Document
Web Page Under Construction
This Site Is Under Construction and Coming Soon. This Domain Is Registered with Network Solutions.
Untitled Document
Untitled Document
